Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy

Pei-Pei Su; Dong-Wei Liu; Si-Jie Zhou; Hang Chen; Xian-Ming Wu; Zhang-Suo Liu

doi:10.1186/s40779-022-00385-0

您当前的位置：

首页 >

文章列表页 >

Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy

RESEARCH | 更新时间：2023-03-23

- Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
- Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
- Pei-Pei Su ，Dong-Wei Liu ，Si-Jie Zhou ，Hang Chen ，Xian-Ming Wu ，Zhang-Suo Liu
- 解放军医学杂志（英文版） 2023年10卷第1期页码：32-44
- 作者机构：
  1.Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Research Institutes of Nephropathy, Zhengzhou University, Zhengzhou 450052 , China
  2.Department of Nephrology and Rheumatology, the Third People’s Hospital of Zhengzhou, Zhengzhou 450002 , China
  3.Henan Province Research Center for Kidney Disease, Zhengzhou 450052, China
  4.Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou 450002, China
- 作者简介：
  * zhangsuoliu@zzu.edu.cn
- 基金信息：
  grants from the Joint construction project of Henan Province(SB201901015);the General Program of the National Natural Science Foundation of China General Project(81970633);the Major public welfare special projects in Henan Province(201300310600);the National Natural Science Young Scientists Foundation of China(81800648);the Excellent Young Scientists Fund Program of the Natural Science Foundation of Henan Province(202300410363)
- DOI： 10.1186/s40779-022-00385-0
  中图分类号：
- 稿件说明：
移动端阅览
DOI：
DOI：

HTML全文
图( 5 ) 表( 0 )
参考文献
出版信息
数据统计

摘要

Abstract

关键词

Keywords

references

59

浏览量

41

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

BibTeX下载
Endnote下载
RefMan 下载
NoteExpress下载
NoteFirst下载

关联资源

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Frostbite: diagnosis, treatment, prognosis, and future directions

Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients